Evidence map›Paper›PMID 37699932›Full record

ArticleScientific reports2023

A 3-4 h oocyte retrieval-ICSI interval optimizes clinical outcomes for women over 40 years.

Jingbo Chen, Yanfang Wang, Cong Fang, Tingting Li

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jingbo ChenReproductive Medicine Research Center, Sixth Affiliated Hospital of Sun Yat-Sen University, NO.17, Shougouling Rd, Guangzhou, 510275, China.
Yanfang WangReproductive Medicine Research Center, Sixth Affiliated Hospital of Sun Yat-Sen University, NO.17, Shougouling Rd, Guangzhou, 510275, China.
Cong FangReproductive Medicine Research Center, Sixth Affiliated Hospital of Sun Yat-Sen University, NO.17, Shougouling Rd, Guangzhou, 510275, China. fangcong@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0001-9352-9525
Tingting LiReproductive Medicine Research Center, Sixth Affiliated Hospital of Sun Yat-Sen University, NO.17, Shougouling Rd, Guangzhou, 510275, China. litt33@mail.sysu.edu.cn.
Guangdong University of Technology · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore an appropriate time interval between oocyte retrieval and intracytoplasmic sperm injection (ICSI) for optimal embryological and clinical outcomes in ICSI cycles over 40 years of maternal age. A retrospective analysis of 1476 ICSI fresh cycles from women aged over 40 years, was performed at the Reproduction Medicine Research Center of the Sixth Affiliated Hospital of Sun Yat-sen University, between December 2013 and August 2020. The fertilization rate and clinical pregnancy rate were the main outcomes. Multivariate linear regression and logistic regression analysis of factors showed that fertilization rate (P = 0.024) and clinical pregnancy rate (P = 0.011) were significantly associated with oocyte pick up (OPU)-ICSI interval. A longer OPU-ICSI interval (no more than 6 h) was associated with a higher fertilization rate but significantly decreased the clinical pregnancy rate when the OPU-ICSI interval was over 4 h (P < 0.05). The optimal OPU-ICSI interval is between 3 and 4 h for excellent embryological and clinical outcomes in ICSI cycles over 40 years of maternal age.

Indexed as

Oocyte RetrievalSemenAdultFemaleHospitalsHumansMaleMiddle AgedPregnancyRetrospective StudiesSperm Injections, Intracytoplasmic

Identifiers

PMID37699932
PMCPMC10497496
OpenAlexW4386686894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.